Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Grover SA et al. – Raising HDL–C levels with commonly used lipid medications appears to be an important determinant of the benefits associated with lipid therapy. These results support the further evaluation of therapies to raise HDL–C levels to prevent CV events.

Related Articles

Management of Hypercholesterolemia
Geriatrics & Aging, 11/12/09    Relevance Score: 94%

Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort
Cancer Causes and Control, 10/13/09    Relevance Score: 92%

Low cholesterol may prevent some prostate cancers
USA Today, 11/05/09    Relevance Score: 91%

Statins Creating a Social Gap in Cholesterol Levels
Internet Source, 10/16/09    Relevance Score: 91%

Study Demonstrates LIVALO Is an Efficacious Treatment for Achieving Lipid Goals
Internet Source, 10/23/09    Relevance Score: 90%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address